# A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma

> **NCT03585725** · EARLY_PHASE1 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 3 (actual)

## Conditions studied

- Follicular Lymphoma
- Mantle Cell Lymphoma

## Interventions

- **DRUG:** Ribavirin

## Key facts

- **NCT ID:** NCT03585725
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-26
- **Primary completion:** 2020-07-22
- **Final completion:** 2020-07-22
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** low accrual
- **Last updated:** 2021-09-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03585725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03585725, "A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03585725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*